Is There Any Research Being Done On Triple Negative Cancers (Breast Cancers That Are Hormone Receptor Negative And Her 2 Negative)?

Question from Lisa Hatter: All the news surrounding breast cancer revolves around hormore receptor positive and Her 2 positive cancers. What about "triple negative" cancers (breast cancers that are hormone receptor negative and Her 2 negative)?

Why isn't more research being done to help with this harder to treat cancer? Is there any good news related to this type of cancer?

Response from Anthony Elias, M.D., University of Colorado Cancer Center:

There is a lot of research going on. First of all, traditional chemotherapy probably works best in this type of breast cancer. There are many new experimental agents that are being evaluated in this particular subtype of breast cancer -- for example, dasatinib, sunitinib, bevacizumab, various EGFR inhibitors, PARP inhibitors and anti-androgens to name a few. It is likely that "triple negatives" will not be just one disease, but actually represent several subtypes.

-- This embed didnt make it to copy for story id = 3736086. -- This embed didnt make it to copy for story id = 3736086. -- This embed didnt make it to copy for story id = 3736086.
Join the Discussion
You are using an outdated version of Internet Explorer. Please click here to upgrade your browser in order to comment.
blog comments powered by Disqus
 
You Might Also Like...